Margaret Alexander's most recent trade in Ovid Therapeutics Inc was a trade of 5,279 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Feb. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 26 Feb 2025 | 5,279 | 73,406 (0%) | 0% | 0.6 | 2,956 | Common Stock |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 262,500 | 262,500 | - | - | Employee Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,750 | 78,685 (0%) | 0% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 27 Jan 2025 | 6,810 | 34,935 (0%) | 0% | 0.7 | 4,971 | Common Stock |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2024 | 140,000 | 140,000 | - | - | Employee Stock Option (right to buy) |